Disproportionality analysis of quinolone safety in children using data from the FDA adverse event reporting system (FAERS)
BackgroundQuinolones are widely prescribed for the treatment or prevention of infectious diseases in children. To gain further insight into quinolone-associated adverse event (AE) in children and better protect pediatric patients, continued surveillance of safety data is essential. The purpose of th...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2023-01-01
|
| Серія: | Frontiers in Pediatrics |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fped.2022.1069504/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|